Somlyo, A V <br/><br/>
Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells.  [electronic resource] 

 -  Biochemical and biophysical research communications  Mar 2000 
 - 652-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-291X 
<br/><br/><label>Standard No.: </label>10.1006/bbrc.2000.2343  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amides--pharmacology<br/>Animals<br/>Azepines--pharmacology<br/>Cattle<br/>Cell Division--drug effects<br/>Cells, Cultured<br/>Chemotaxis--drug effects<br/>Endothelium, Vascular--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Humans<br/>Intracellular Signaling Peptides and Proteins<br/>Male<br/>Mice<br/>Mice, Transgenic<br/>Myosin-Light-Chain Kinase--antagonists & inhibitors<br/>Myosin-Light-Chain Phosphatase<br/>Neoplasm Invasiveness--prevention & control<br/>Neoplasm Metastasis--prevention & control<br/>Neovascularization, Physiologic--drug effects<br/>Phosphoprotein Phosphatases--antagonists & inhibitors<br/>Prostatic Neoplasms--pathology<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Pyridines--pharmacology<br/>Transplantation, Heterologous<br/>Tumor Cells, Cultured<br/>rho-Associated Kinases